MBK-01
- Generic Name
- MBK-01
Clinical Trial With MBK-01, Intestinal Microbiota Capsules, for the Treatment of Patients With Recurrent Diverticulitis
Phase 2
Not yet recruiting
- Conditions
- DiverticulitisDiverticulitis of Sigmoid
- Interventions
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Mikrobiomik Healthcare Company S.L.
- Target Recruit Count
- 81
- Registration Number
- NCT06687382
- Locations
- 🇪🇸
Hospital Universitario Ramón y Cajal, Madrid, Spain
Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin
Phase 3
Completed
- Conditions
- Recurrent Clostridium Difficile InfectionPrimary Clostridium Difficile Infection
- Interventions
- First Posted Date
- 2022-01-21
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Mikrobiomik Healthcare Company S.L.
- Target Recruit Count
- 93
- Registration Number
- NCT05201079
- Locations
- 🇪🇸
Hospital Universitario de Cruces, Barakaldo, Spain
🇪🇸Hospital Universitario de Basurto, Bilbao, Spain
🇪🇸Hospital Universitario Reina SofÃa, Córdoba, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath